These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22771300)

  • 21. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 23. Symposium on thrombosis and antithrombotic therapy--1986.
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):1B-167B. PubMed ID: 3782650
    [No Abstract]   [Full Text] [Related]  

  • 24. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombotic management in patients with prosthetic valves: a comparison of American and European guidelines.
    Butchart EG
    Heart; 2009 Mar; 95(5):430-6. PubMed ID: 19218268
    [No Abstract]   [Full Text] [Related]  

  • 26. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians.
    Hirsh J; Dalen J; Guyatt G;
    Chest; 2001 Jan; 119(1 Suppl):1S-2S. PubMed ID: 11157638
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of antithrombotics in secondary stroke prevention.
    Lazzaro MA; Malhotra K; Mohammad YM
    Semin Neurol; 2010 Nov; 30(5):492-500. PubMed ID: 21207341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a need for antithrombotic prophylaxis during laparascopic surgery? Always.
    Rasmussen MS
    J Thromb Haemost; 2005 Feb; 3(2):210-1. PubMed ID: 15670018
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
    Patti G; Di Sciascio G
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.
    Fauchier L; Lip GY
    Europace; 2010 Jun; 12(6):761-3. PubMed ID: 20388635
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disorders.
    Finazzi G
    Lupus; 2012 Jun; 21(7):747-50. PubMed ID: 22635221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis.
    Nelson RS; Ewing BM; Ternent C; Shashidharan M; Blatchford GJ; Thorson AG
    Am J Surg; 2008 Dec; 196(6):994-9; discussion 999. PubMed ID: 19095121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hitting the target with antithrombotic therapy.
    Fritsma MG; Rodak BF
    MLO Med Lab Obs; 2007 May; 39(5):22, 24, 26 passim. PubMed ID: 18396734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New antithrombotic drugs].
    Le Heuzey JY
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S64-6. PubMed ID: 20103187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Re: New guidelines for antithrombotic therapy and thromboprophylaxis].
    Stormorken H
    Tidsskr Nor Laegeforen; 2014 Jul; 134(12-13):1216. PubMed ID: 24989189
    [No Abstract]   [Full Text] [Related]  

  • 38. Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy.
    Lichtenstein AH
    Thromb Res; 2005; 117(1-2):71-3; discussion 113-5. PubMed ID: 15951007
    [No Abstract]   [Full Text] [Related]  

  • 39. Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches.
    Sabatier B; Trinquart L; Emmerich J
    Arch Cardiovasc Dis; 2010 Oct; 103(10):497-501. PubMed ID: 21130962
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical implications for patients on antithrombotic therapy while taking supplements.
    Ortel TL
    Thromb Res; 2005; 117(1-2):75-80; discussion 113-5. PubMed ID: 15961141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.